CyberAgent, Inc. (CYGIY)

Inozyme Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	5,479	3,603	2,732	4,259	9,810	7,735
Market Cap Growth	82.68%	31.87%	-35.84%	-56.59%	26.83%	59.96%
Enterprise Value	5,250	3,409	2,651	3,806	9,390	7,603
Last Close Price	5.21	3.67	2.54	4.96	9.36	7.16
PE Ratio	30.85	32.31	115.28	26.91	26.53	124.23
PS Ratio	0.94	0.64	0.57	0.87	1.64	1.71
PB Ratio	2.89	2.06	1.79	2.79	5.65	6.39
P/TBV Ratio	6.69	4.74	3.73	5.04	10.58	12.37
P/FCF Ratio	-	11.09	52.70	604.13	10.35	24.77
P/OCF Ratio	-	9.70	19.60	34.34	9.98	22.03
EV/Sales Ratio	0.93	0.61	0.55	0.78	1.57	1.68
EV/EBITDA Ratio	11.55	9.78	13.07	7.22	9.18	18.84
EV/EBIT Ratio	14.11	12.37	17.85	8.15	10.07	23.70
EV/FCF Ratio	-	10.49	51.13	539.88	9.90	24.35
Debt / Equity Ratio	0.35	0.43	0.47	0.21	0.22	0.33
Debt / EBITDA Ratio	1.44	2.14	3.54	0.61	0.37	0.97
Debt / FCF Ratio	-	2.29	13.83	45.35	0.40	1.26
Asset Turnover	1.63	1.62	1.68	1.86	2.07	1.97
Inventory Turnover	62.01	56.63	79.73	131.26	163.82	225.13
Quick Ratio	2.05	1.84	2.23	1.95	1.96	2.10
Current Ratio	2.40	2.13	2.59	2.25	2.14	2.32
Return on Equity (ROE)	12.10%	8.51%	4.07%	18.36%	41.29%	11.95%
Return on Assets (ROA)	6.71%	4.98%	3.23%	11.05%	20.22%	8.71%
Return on Capital (ROIC)	9.56%	7.12%	4.60%	16.76%	32.07%	13.18%
Return on Capital Employed (ROCE)	14.60%	11.30%	6.50%	26.80%	43.10%	19.60%
Earnings Yield	3.24%	3.09%	0.87%	3.72%	3.77%	0.80%
FCF Yield	-	9.02%	1.90%	0.17%	9.67%	4.04%
Dividend Yield	326.30%	3.04%	3.95%	1.95%	1.05%	1.13%
Payout Ratio	-	47.45%	199.86%	24.26%	10.40%	63.30%
Buyback Yield / Dilution	-1.41%	-0.77%	-2.06%	-0.03%	-0.14%	-0.06%
Total Shareholder Return	324.88%	2.27%	1.89%	1.92%	0.92%	1.06%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.